Organic Letters
Letter
Scheme 4. Total Synthesis of (+)-Pestalazine B (3) via an
Aldol Reaction−Deoxygenation Strategy
ACKNOWLEDGMENTS
■
This work was supported by the Drug Discovery and Life
Science Research (BINDS) from AMED under Grant Nos.
JP18am0101100 and JSPS KAKENHI Grant Nos.
JP18H04379 in Middle Molecular Strategy, JP18H04231 in
Precisely Designed Catalysts with Customized Scaffolding, and
JP18H04642 in Hybrid Catalysis and Grants-in-aid for
Scientific Research (B) (18H02549) and (C) (17K08204).
REFERENCES
■
́
(1) (a) Ruiz-Sanchis, P.; Savina, S. A.; Albericio, F.; Alvarez, M.
Chem. - Eur. J. 2011, 17, 1388−1408. (b) Tadano, S.; Ishikawa, H.
Synlett 2014, 25, 157−162. (c) Kim, J.; Movassaghi, M. Acc. Chem.
Res. 2015, 48, 1159−1171.
(2) Zhou, H.; He, H.-P.; Wang, Y.-H.; Hao, X.-J. Helv. Chim. Acta
2010, 93, 1650−1652.
(3) Kung, A. L.; Zabludoff, S. D.; France, D. S.; Freedman, S. J.;
Tanner, E. A.; Vieira, A.; Cornell-Kennon, S.; Lee, J.; Wang, B.; Wang,
J. M.; Memmert, K.; Naegeli, H. U.; Peterson, F.; Eck, M. J.; Bair, K.
W.; Wood, A. W.; Livingston, D. M. Cancer Cell 2004, 6, 33−43.
(4) For representative total syntheses of the bis-indole alkaloid
vinblastine, see: (a) Yokoshima, S.; Ueda, T.; Kobayashi, S.; Sato, A.;
Kuboyama, T.; Tokuyama, H.; Fukuyama, T. J. Am. Chem. Soc. 2002,
124, 2137−2139. (b) Ishikawa, H.; Colby, D. A.; Seto, S.; Va, P.;
Tam, A.; Kakei, H.; Rayl, T. J.; Hwang, I.; Boger, D. L. J. Am. Chem.
Soc. 2009, 131, 4904−4916.
(5) For selected examples of syntheses of C−C-linked pyrroloindo-
lines with indoles, see: (a) Yamada, F.; Goto, A.; Somei, M.
Heterocycles 2000, 53, 1255−1258. (b) Furst, L.; Narayanam, J. M. R.;
Stephenson, C. R. J. Angew. Chem., Int. Ed. 2011, 50, 9655−9659.
(c) Kim, J.; Movassaghi, M. J. Am. Chem. Soc. 2011, 133, 14940−
14943. (d) Boyer, N.; Movassaghi, M. Chem. Sci. 2012, 3, 1798−
1803. (e) Tayu, M.; Higuchi, K.; Ishizaki, T.; Kawasaki, T. Org. Lett.
2014, 16, 3613−3615. (f) Lei, H.; Wang, L.; Xu, Z.; Ye, T. Org. Lett.
2017, 19, 5134−5137. (g) Tayu, M.; Hui, Y.; Takeda, S.; Higuchi, K.;
Saito, N.; Kawasaki, T. Org. Lett. 2017, 19, 6582−6585. (h) Wang, X.;
Ma, G.; Peng, Y.; Pitsch, C. E.; Moll, B. J.; Ly, T. D.; Wang, X.; Gong,
H. J. Am. Chem. Soc. 2018, 140, 14490−14497.
(6) (a) Espejo, V. R.; Rainier, J. D. J. Am. Chem. Soc. 2008, 130,
12894−12895. (b) Espejo, V. R.; Rainier, J. D. Org. Lett. 2010, 12,
2154−2157.
(7) (a) Villanueva-Margalef, I.; Thurston, D. E.; Zinzalla, G. Org.
Biomol. Chem. 2010, 8, 5294−5303. (b) Welch, T. R. Dissertation,
Colorado State University, 2012. (c) Welch, T. R.; Williams, R. M.
Tetrahedron 2013, 69, 770−773.
(8) (a) Newhouse, T.; Baran, P. S. J. Am. Chem. Soc. 2008, 130,
10886−10887. (b) Foo, K.; Newhouse, T.; Mori, I.; Takayama, H.;
Baran, P. S. Angew. Chem., Int. Ed. 2011, 50, 2716−2719. (c) Liu, C.;
Yi, J.-C.; Zheng, Z.-B.; Tang, Y.; Dai, L.-X.; You, S.-L. Angew. Chem.,
Int. Ed. 2016, 55, 751−754. (d) Adhikari, A. A.; Chisholm, J. D. Org.
Lett. 2016, 18, 4100−4103. (e) Dai, J.; Xiong, D.; Yuan, T.; Liu, J.;
Chen, T.; Shao, Z. Angew. Chem., Int. Ed. 2017, 56, 12697−12701.
(f) Gentry, E. C.; Rono, L. J.; Hale, M. E.; Matsuura, R.; Knowles, R.
R. J. Am. Chem. Soc. 2018, 140, 3394−3402.
(9) (a) Matsuda, Y.; Kitajima, M.; Takayama, H. Org. Lett. 2008, 10,
125−128. (b) Araki, T.; Ozawa, T.; Yokoe, H.; Kanematsu, M.;
Yoshida, M.; Shishido, K. Org. Lett. 2013, 15, 200−203. (c) Zhang,
H.; Kang, H.; Hong, L.; Dong, W.; Li, G.; Zheng, X.; Wang, R. Org.
Lett. 2014, 16, 2394−2397. (d) Tayu, M.; Ishizaki, T.; Higuchi, K.;
Kawasaki, T. Org. Biomol. Chem. 2015, 13, 3863−3865. (e) Lian, X.-
L.; Meng, J.; Han, Z.-Y. Org. Lett. 2016, 18, 4270−4273.
with aldehyde 17 in the presence of DMPU. The desired aldol
was obtained as a mixture of diastereomers, which was
subjected to the Barton−McCombie protocol to furnish
deoxygenated product. Finally, a Boc and two ethyl groups
were removed under Lewis acidic conditions to achieve the
total synthesis of (+)-pestalazine B (3). All of the spectral data
were identical with those reported in de Lera’s total synthesis,
unambiguous supporting de Lera’s structural revision.14a
In summary, we have developed a novel AgNTf2-mediated
amination/cyclization cascade for constructing an N-linked
indole segment at the 3a-position of pyrroloindolines. This
cascade process is a novel entry of a Ag salt mediated tandem
reaction, in which AgNTf2 plays a dual role: activation of a
bromo group and an alkyne moiety. Owing to the mildness of
the Ag salt mediated activation, the established reaction
conditions displayed high functional group compatibility. The
utility of our process for synthesizing bis-indole alkaloids was
fully demonstrated by the total synthesis of (+)-pestalazine B.
In view of the general applicability of this protocol to
constructing a broad range of scaffolds such as pyrroloindo-
lines, furoindolines, and tetrahydro-α-carboline, this modular
synthetic strategy integrating three building blocks, involving
bromopyrroloindoline, alkynylanilines, and an imidate unit,
should pave the way to accessing various natural and synthetic
dimeric indole compounds.
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
Experimental details and procedures, compound char-
acterization data, and copies of 1H and 13C NMR spectra
for all new compounds (PDF)
AUTHOR INFORMATION
■
Corresponding Author
ORCID
(10) (a) Satoh, H.; Ojima, K.; Ueda, H.; Tokuyama, H. Angew.
Chem., Int. Ed. 2016, 55, 15157−15161. (b) Sato, S.; Hirayama, A.;
Ueda, H.; Tokuyama, H. Asian J. Org. Chem. 2017, 6, 54−58.
(c) Hakamata, H.; Sato, S.; Ueda, H.; Tokuyama, H. Org. Lett. 2017,
19, 5308−5311. (d) Sato, S.; Hirayama, A.; Adachi, T.; Kawauchi, D.;
Ueda, H.; Tokuyama, H. Heterocycles 2017, 94, 1940−1957.
Notes
The authors declare no competing financial interest.
D
Org. Lett. XXXX, XXX, XXX−XXX